Both companies have been disrupted and will need to reinvent themselves to become successful. There is certainly some value in the assets (IP for iRobot and subscriber base for Chegg) that could make them attractive to a strategic buyer at the right price.
Interesting that many small companies like Chegg and iRobot will remain standalone public companies.
While high risk, could provide compelling returns over the next few years if successful.
Both companies have been disrupted and will need to reinvent themselves to become successful. There is certainly some value in the assets (IP for iRobot and subscriber base for Chegg) that could make them attractive to a strategic buyer at the right price.
The spinoff of all the other assets is also interesting and reminds me of what Pfizer did after it acquired Biohaven.